We also find that postnatal ketanserin treatment prevents the enhanced expression of specific genes (Prkcb1, Ppp3ca) implicated in altered 5-HT2A receptor signaling (53–55) in the PFC of MS animals in adulthood. Here, PRKCB is linked to myeloid sarcoma.